↓ Skip to main content

Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review

Overview of attention for article published in BMC Pharmacology and Toxicology, January 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
43 Mendeley
Title
Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review
Published in
BMC Pharmacology and Toxicology, January 2015
DOI 10.1186/2050-6511-16-1
Pubmed ID
Authors

Andrea C Tricco, Charlene Soobiah, Wing Hui, Jesmin Antony, Vladi Struchkov, Brian Hutton, Brenda Hemmelgarn, David Moher, Sharon E Straus

Abstract

Patients may experience nausea and vomiting when undergoing chemotherapy or surgery requiring anesthesia. Serotonin 5-hydroxytryptamine 3 (5-HT3) receptor antagonists are effective antiemetics, yet may cause adverse cardiac events, such as arrhythmia. We aimed to identify interventions that mitigate the cardiac risk of 5-HT3 receptor antagonists.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Colombia 1 2%
Unknown 41 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 16%
Other 6 14%
Researcher 4 9%
Student > Ph. D. Student 4 9%
Student > Bachelor 3 7%
Other 7 16%
Unknown 12 28%
Readers by discipline Count As %
Medicine and Dentistry 14 33%
Pharmacology, Toxicology and Pharmaceutical Science 5 12%
Engineering 2 5%
Nursing and Health Professions 1 2%
Psychology 1 2%
Other 3 7%
Unknown 17 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 January 2015.
All research outputs
#4,169,227
of 22,780,165 outputs
Outputs from BMC Pharmacology and Toxicology
#69
of 439 outputs
Outputs of similar age
#60,248
of 352,182 outputs
Outputs of similar age from BMC Pharmacology and Toxicology
#2
of 10 outputs
Altmetric has tracked 22,780,165 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 439 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,182 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 8 of them.